Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer Chau Dang Clinical Trials Report 18 April 2009 Pages: 1 - 2
The role of adjuvant anthracyclines for breast cancer treatment: Can we use molecular predictors? Chau DangClifford Hudis OriginalPaper 18 April 2009 Pages: 5 - 11
How do we evaluate sentinel nodes and interpret the findings? Hiram S. Cody III OriginalPaper 18 April 2009 Pages: 12 - 20
Neoadjuvant therapy for breast cancer: Assessing treatment progress and managing poor responders Robert WesolowskiGeorge Thomas Budd OriginalPaper 18 April 2009 Pages: 21 - 28
Concurrent use of chemotherapy or novel agents in combination with radiation in breast cancer Kevin KalinskyAlice HoAndrew Seidman OriginalPaper 18 April 2009 Pages: 29 - 41
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer? Michaela J. HigginsNancy E. Davidson OriginalPaper 18 April 2009 Pages: 42 - 47
Is chemoprevention practical? Carol J. FabianBruce F. Kimler OriginalPaper 18 April 2009 Pages: 48 - 53
Bisphosphonates as adjuvant therapy for breast cancer Michael GnantPeter DubskyRichard Greil OriginalPaper 18 April 2009 Pages: 54 - 63